References
- Darby SC, McGale P, Taylor CW, Peto R. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol 2005; 6: 557–65. doi: 10.1016/s1470-2045(05)70251-5
- Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Brønnum D, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 2013; 368: 987–98. doi: 10.1056/NEJMoa1209825
- Zhang J, Jiang S, Zhang R, Zhang L. Increased 18F-FAPI uptake in radiation-induced liver injury. Clin Nucl Med 2023; 48: e474–e6. doi:10.1097/RLU.0000000000004801
- Adediran OA, Lawal IO, Muzahir S, Bhave MA, Friend S, Fielder B, et al. A discordant pattern of uptake on 68Ga-PSMA PET/CT versus 18F-Fluciclovine PET/CT in radiation-induced hepatitis: implications for early postradiotherapy imaging-based response assessment. Clin Nucl Med 2023; 48: e202–e3. doi: 10.1097/RLU.0000000000004565
- Haji G, Nabizade U, Kazimov K, Guliyeva N, Isayev I. Liver dose reduction by deep inspiration breath hold technique in right-sided breast irradiation. Radiat Oncol J 2019; 37: 254–8. doi: 10.3857/roj.2019.00206
- Nissen HD, Appelt AL. Improved heart, lung and target dose with deep inspiration breath hold in a large clinical series of breast cancer patients. Radiother Oncol 2013; 106: 28–32. 10.1016/j.radonc.2012.10.016
- Malnick SDH, Alin P, Somin M, Neuman MG. Fatty liver disease-alcoholic and non-alcoholic: similar but different. Int J Mol Sci 2022; 23: 16226. doi: 10.3390/ijms232416226
- Navin PJ, Olson MC, Mendiratta-Lala M, Hallemeier CL, Torbenson MS, Venkatesh SK. Imaging features in the liver after stereotactic body radiation therapy. Radiographics 2022; 42: 2131–48. doi: 10.1148/rg.220084
- Hama Y, Tate E. MRI-guided stereotactic ablative radiation therapy for liver metastasis from pancreatic cancer. J Cancer Res Ther 2022; 18(Supp): S489–92. doi: 10.4103/jcrt.JCRT_1091_20
- Venkatesh SK, Ehman RL. Magnetic resonance elastography of liver. Magn Reson Imaging Clin N Am 2014; 22: 433–46. doi: 10.1016/j.mric.2014.05.001
- Venkatesh SK, Yin M, Ehman RL. Magnetic resonance elastography of liver: technique, analysis, and clinical applications. J Magn Reson Imaging 2013; 37: 544–55. doi: 10.1002/jmri.23731
- Idilman IS, Karcaaltincaba M. The role of magnetic resonance elastography in the evaluation of nonalcoholic fatty liver disease. Hepatol Forum 2023; 4: 1–2. doi: 10.14744/hf.2023.2023.0004
- Chiang CL, Chiu KWH, Chan KSK, Lee FAS, Li JCB, Wan CWS, et al. Sequential transarterial chemoembolisation and stereotactic body radiotherapy followed by immunotherapy as conversion therapy for patients with locally advanced, unresectable hepatocellular carcinoma (START-FIT): a single-arm, phase 2 trial. Lancet Gastroenterol Hepatol 2023; 8: 169–78. doi: 10.1016/S2468-1253(22)00339-9
- Nielsen J, Kjær MS, Rasmussen A, Chiranth D, Willemoe GL, Henriksen BM, et al. Noninvasive prediction of advanced fibrosis in pediatric liver disease-discriminatory performance of 2D shear wave elastography, transient elastography and magnetic resonance elastography in comparison to histopathology. Diagnostics 2022; 12: 2785. doi: 10.3390/diagnostics12112785
- Gheorghe G, Bungău S, Ceobanu G, Ilie M, Bacalbaşa N, Bratu OG, et al. The non-invasive assessment of hepatic fibrosis. J Formos Med Assoc 2021; 120: 794–803. doi: 10.1016/j.jfma.2020.08.019
- Hsu C, Caussy C, Imajo K, Chen J, Singh S, Kaulback K, et al. Magnetic resonance vs transient elastography analysis of patients with nonalcoholic fatty liver disease: a systematic review and pooled analysis of individual participants. Clin Gastroenterol Hepatol 2019; 17: 630–7.e8. doi: 10.1016/j.cgh.2018.05.059
- Petroff D, Blank V, Newsome PN, Shalimar, Voican CS, Thiele M, et.al. Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis. Lancet Gastroenterol Hepatol 2021; 6: 185–98. doi: 10.1016/S2468-1253(20)30357-5
- Eddowes PJ, Sasso M, Allison M, Tsochatzis E, Anstee QM, Sheridan D, et al. Accuracy of FibroScan Controlled Attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology 2019; 156: 1717–30. doi: 10.1053/j.gastro.2019.01.042
- Jun BG, Kim YD, Cheon GJ, Kim ES, Jwa E, Kim SG, et al. Clinical significance of radiation-induced liver disease after stereotactic body radiation therapy for hepatocellular carcinoma. Korean J Intern Med 2018; 33: 1093–2. doi: 10.3904/kjim.2016.412
- Treiber T, Treiber N, Meister G. Regulation of microRNA biogenesis and its crosstalk with other cellular pathways. Nat Rev Mol Cell Biol 2019; 20: 5–20. doi: 10.1038/s41580-018-0059-1
- Lauffer DC, Miglierini P, Kuhn PA, Thalmann SU, Gutierres-Demierre N, Khomsi F, et al. Impact of adjuvant radiotherapy on biological and clinical parameters in right-sided breast cancer. Cancer Radiother 2021; 25: 469–75. doi: 10.1016/j.canrad.2021.04.007
- Zhou YJ, Tang Y, Liu SJ, Zeng PH, Qu L, Jing QC, et al. Radiation-induced liver disease: beyond DNA damage. Cell Cycle 2023; 22: 506–26. doi: 10.1080/15384101.2022.2131163
- Agbim U, Asrani SK. Non-invasive assessment of liver fibrosis and prognosis: an update on serum and elastography markers. Expert Rev Gastroenterol Hepatol 2019; 13: 361–74. doi: 10.1080/17474124.2019.1579641
- Bi J, Liu L, Qin T. Comparison of magnetic resonance elastography and transient elastography in the diagnosis of hepatic fibrosis: a systematic review and meta-analysis. Ann Palliat Med 2021; 10: 8692–700. doi: 10.21037/apm-21-1176
- Ajmera VH, Liu A, Singh S, Yachoa G, Ramey M, Bhargava M, et al. Clinical utility of an increase in magnetic resonance elastography in predicting fibrosis progression in nonalcoholic fatty liver disease. Hepatology 2020; 71: 849–60. doi: 10.1002/hep.30974
- Tamaki N, Imajo K, Sharpton S, Jung J, Kawamura N, Yoneda M, et al. Magnetic resonance elastography plus fibrosis-4 versus fibroscan-aspartate aminotransferase in detection of candidates for pharmacological treatment of NASH-related fibrosis. Hepatology 2022; 75: 661–72. doi: 10.1002/hep.32145
- Gidener T, Ahmed OT, Larson JJ, Mara KC, Therneau TM, Venkatesh SK, et al. Liver stiffness by magnetic resonance elastography predicts future cirrhosis, decompensation, and death in NAFLD. Clin Gastroenterol Hepatol 2021; 19: 1915–24.e6. doi: 10.1016/j.cgh.2020.09.044
- Ajmera V, Kim BK, Yang K, Majzoub AM, Nayfeh T, Tamaki N, et al. Liver stiffness on magnetic resonance elastography and the MEFIB index and liver-related Outcomes in Nonalcoholic Fatty Liver Disease: a systematic review and meta-analysis of individual participants. Gastroenterology 2022; 163: 1079–89.e5. doi: 10.1053/j.gastro.2022.06.073